(VIANEWS) – The Herzfeld Caribbean Basin Fund (CUBA), Duff & Phelps Global Utility Income Fund (DPG), John Hancock Hedged Equity & Income Fund (HEQ) are the highest dividend yield stocks on this list.

Rank Financial Asset Price Change Forward Dividend Yield Updated (EST)
1 The Herzfeld Caribbean Basin Fund (CUBA) 6.30 0.16% 10.18% 2021-07-05 13:48:25
2 Duff & Phelps Global Utility Income Fund (DPG) 14.47 -1.16% 9.64% 2021-07-09 03:51:04
3 John Hancock Hedged Equity & Income Fund (HEQ) 13.66 0.48% 9.11% 2021-07-09 10:23:21
4 SINOPEC Shangai Petrochemical Company, Ltd. (SHI) 23.33 1.39% 6.53% 2021-07-10 01:42:24
5 Cyclacel Pharmaceuticals (CYCCP) 9.60 -2.05% 6.17% 2021-07-05 14:13:05
6 Sturm, Ruger & Company (RGR) 81.76 0.74% 4.12% 2021-07-10 00:11:05
7 Healthcare Realty Trust Incorporated (HR) 30.32 0.31% 4% 2021-07-09 11:15:06
8 Elbit Imaging Ltd. (EMITF) 2.54 0% 3.68% 2021-07-05 16:14:26
9 American Assets Trust (AAT) 36.59 -0.95% 2.98% 2021-07-08 15:52:09
10 Chesapeake Energy Corporation (CHK) 54.61 0.65% 2.5% 2021-07-08 23:14:25

A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. The Herzfeld Caribbean Basin Fund (CUBA) – Dividend Yield: 10.18%

The Herzfeld Caribbean Basin Fund Inc. is a closed-ended equity mutual fund launched by Thomas J. Herzfeld Advisors, Inc. The fund is managed by Herzfeld/Cuba. It invests in the public equity markets of the United States. The fund employing fundamental analysis investing in stocks of companies that are likely to benefit from economic, political, structural and technological developments in the countries in the Caribbean Basin, which consist of Cuba, Jamaica, Trinidad and Tobago, the Bahamas, the Dominican Republic, Barbados, Aruba, Haiti, the Netherlands Antilles, the Commonwealth of Puerto Rico, Mexico, Honduras, Guatemala, Belize, Costa Rica, Panama, Colombia and Venezuela. It invests in stocks of companies operating across diversified sectors. The Herzfeld Caribbean Basin Fund Inc. was formed on March 10, 1992 and is domiciled in the United States.

Volume

Today’s last reported volume for The Herzfeld Caribbean Basin Fund is 56372, 151.38% above its average volume of 22425.

The Herzfeld Caribbean Basin Fund’s last close was $6.39, 8.97% below its 52-week high of $7.02.

The Herzfeld Caribbean Basin Fund’s Revenue

Year-on-year quarterly revenue growth declined by 43.7%, now sitting on 482.49k for the twelve trailing months.

The Herzfeld Caribbean Basin Fund’s Stock Yearly Top and Bottom Value

The Herzfeld Caribbean Basin Fund’s stock is valued at $6.30 at 14:15 EST, way below its 52-week high of $7.02 and way higher than its 52-week low of $3.34.

The Herzfeld Caribbean Basin Fund’s Moving Average

The Herzfeld Caribbean Basin Fund’s value is below its 50-day moving average of $6.32 and higher than its 200-day moving average of $5.94.

More news about The Herzfeld Caribbean Basin Fund.

2. Duff & Phelps Global Utility Income Fund (DPG) – Dividend Yield: 9.64%

Duff & Phelps Utility and Infrastructure Fund Inc is a closed-ended equity mutual fund launched by Virtus Investment Partners, Inc. The fund is managed by Duff & Phelps Investment Management Co. It invests in the public equity markets across the globe. The fund seeks to invest in the companies operating in utility sector. It invests in stocks of companies across diversified market capitalizations. The fund was formerly known as Duff & Phelps Global Utility Income Fund Inc. Duff & Phelps Utility and Infrastructure Fund Inc. was formed on July 29, 2011 and is domiciled in the United States.

Volume

Today’s last reported volume for Duff & Phelps Global Utility Income Fund is 196800, 37.38% above its average volume of 143254.

Duff & Phelps Global Utility Income Fund’s last close was $14.90, 3.31% under its 52-week high of $15.41.

Duff & Phelps Global Utility Income Fund’s Stock Yearly Top and Bottom Value

Duff & Phelps Global Utility Income Fund’s stock is valued at $14.47 at 14:15 EST, under its 52-week high of $15.41 and way above its 52-week low of $9.80.

Duff & Phelps Global Utility Income Fund’s Moving Average

Duff & Phelps Global Utility Income Fund’s worth is below its 50-day moving average of $14.70 and above its 200-day moving average of $13.70.

More news about Duff & Phelps Global Utility Income Fund.

3. John Hancock Hedged Equity & Income Fund (HEQ) – Dividend Yield: 9.11%

John Hancock Hedged Equity & Income Fund is a closed-ended equity mutual fund launched and managed by John Hancock Investment Management LLC. The fund is co-managed by Wellington Management Company LLP. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It invests in stocks of companies across all market capitalizations. The fund also invests through derivatives such as call options and equity futures. John Hancock Hedged Equity & Income Fund was formed on May 26, 2011 and is domiciled in the United States.

Volume

Today’s last reported volume for John Hancock Hedged Equity & Income Fund is 21311, 63.18% below its average volume of 57879.

John Hancock Hedged Equity & Income Fund’s last close was $12.78, 6.44% under its 52-week high of $13.66.

John Hancock Hedged Equity & Income Fund’s Stock Yearly Top and Bottom Value

John Hancock Hedged Equity & Income Fund’s stock is valued at $13.66 at 14:15 EST, way below its 52-week low of $9.72.

John Hancock Hedged Equity & Income Fund’s Moving Average

John Hancock Hedged Equity & Income Fund’s worth is higher than its 50-day moving average of $12.96 and way above its 200-day moving average of $12.13.

More news about John Hancock Hedged Equity & Income Fund.

4. SINOPEC Shangai Petrochemical Company, Ltd. (SHI) – Dividend Yield: 6.53%

Sinopec Shanghai Petrochemical Company Limited, together with its subsidiaries, manufactures and sells petrochemical products in the People's Republic of China. It operates through five segments: Synthetic Fibres, Resins and Plastics, Intermediate Petrochemical Products, Petroleum Products, and Trading of Petrochemical Products. The Synthetic Fibres segment produces polyesters, acrylic fibers, and carbon fibers that are primarily used in the textile and apparel industries. The Resins and Plastics segment produces polyester chips that are used to produce polyester fibers, coating, and containers; polyethylene resins and plastics, which are used to produce insulated cables and mulching films, as well as molded products, such as housewares and toys; and polypropylene resins that are used for films and sheets, as well as molded products, such as housewares, toys, consumer electronics, and automobile parts; and PVA granules. The Intermediate Petrochemical Products segment produces p-xylene, benzene, and ethylene oxide, which are used as raw materials in the production of other petrochemicals, resins, plastics, and synthetic fibers. The Petroleum Products segment operates crude oil distillation facilities that produce vacuum and atmospheric gas oils used as feedstock; and residual oil and low octane gasoline fuels, as well as produces various fuels, such as diesel oil, jet fuel, heavy oil, and liquefied petroleum gas for transportation, industry, and household heating applications. The Trading of Petrochemical Products segment is involved in the import and export of petrochemical products. The company was founded in 1972 and is based in Shanghai, the People's Republic of China. Sinopec Shanghai Petrochemical Company Limited is a subsidiary of China Petroleum & Chemical Corporation.

Volume

Today’s last reported volume for SINOPEC Shangai Petrochemical Company, Ltd. is 20958, 39.28% below its average volume of 34517.

SINOPEC Shangai Petrochemical Company, Ltd.’s last close was $25.47, 4.96% under its 52-week high of $26.80.

SINOPEC Shangai Petrochemical Company, Ltd.’s Revenue

Year-on-year quarterly revenue growth grew by 13.7%, now sitting on 77.16B for the twelve trailing months.

SINOPEC Shangai Petrochemical Company, Ltd.’s Stock Yearly Top and Bottom Value

SINOPEC Shangai Petrochemical Company, Ltd.’s stock is valued at $23.33 at 14:15 EST, way below its 52-week high of $26.80 and way above its 52-week low of $17.03.

SINOPEC Shangai Petrochemical Company, Ltd.’s Moving Average

SINOPEC Shangai Petrochemical Company, Ltd.’s worth is under its 50-day moving average of $24.93 and under its 200-day moving average of $24.14.

More news about SINOPEC Shangai Petrochemical Company, Ltd..

5. Cyclacel Pharmaceuticals (CYCCP) – Dividend Yield: 6.17%

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include CYC065, a cyclin dependent kinase Inhibitors (CDK) that is in Phase I clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-like kinase inhibitor program, which is in Phase I clinical trial for the treatment of advanced leukemias. Its oncology development programs also comprise sapacitabine, an oral nucleoside analogue prodrug that is in Phase 1/2 combination study with seliciclib, a CDK inhibitor in patients with BRCA mutations; with olaparib, a poly ADP-ribose polymerase inhibitor in BRCA mutation positive patients with breast cancer; and Phase III clinical trial for the treatment of acute myeloid leukemia. In addition, the company's oncology development programs include seliciclib, a CDK inhibitor that is in all-oral Phase 1/2 combination study with sapacitabine for BRCA mutations. It has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias; and collaboration, licensing, and supply agreement with ManRos Therapeutics SA for the development and commercialization of oral seliciclib capsules for the treatment of cystic fibrosis. Cyclacel Pharmaceuticals, Inc. was founded in 1992 and is headquartered in Berkeley Heights, New Jersey.

Volume

Today’s last reported volume for Cyclacel Pharmaceuticals is 0, 100% below its average volume of 326.

Cyclacel Pharmaceuticals’s last close was $9.38, 10.5% under its 52-week high of $10.48.

Cyclacel Pharmaceuticals’s Stock Yearly Top and Bottom Value

Cyclacel Pharmaceuticals’s stock is valued at $9.60 at 14:15 EST, below its 52-week high of $10.48 and way above its 52-week low of $4.81.

Cyclacel Pharmaceuticals’s Moving Average

Cyclacel Pharmaceuticals’s value is higher than its 50-day moving average of $9.55 and way higher than its 200-day moving average of $8.42.

More news about Cyclacel Pharmaceuticals.

6. Sturm, Ruger & Company (RGR) – Dividend Yield: 4.12%

Sturm, Ruger & Company, Inc., together with its subsidiaries, designs, manufactures, and sells firearms under the Ruger name and trademark in the United States. It operates in two segments, Firearms and Castings. The company provides single-shot, autoloading, bolt-action, and sporting rifles; rimfire and centerfire autoloading pistols; single-action and double-action revolvers; and firearms accessories and replacement parts. The company also manufactures and sells steel investment castings and metal injection molding (MIM) parts. It sells its firearm products through independent wholesale distributors principally to the commercial sporting market; and castings and MIM parts directly or through manufacturers' representatives. The company also exports its firearm products through a network of commercial distributors and directly to foreign customers comprising primarily of law enforcement agencies and foreign governments. Sturm, Ruger & Company, Inc. was founded in 1949 and is based in Southport, Connecticut.

Volume

Today’s last reported volume for Sturm, Ruger & Company is 186974, 12.64% below its average volume of 214035.

Sturm, Ruger & Company’s last close was $77.99, 15.68% below its 52-week high of $92.49.

Sturm, Ruger & Company’s Sales

Sturm, Ruger & Company’s sales growth is 35% for the present quarter and 13.8% for the next. The company’s growth estimates for the present quarter and the next is 63.8% and 9.4%, respectively.

Sturm, Ruger & Company’s Revenue

Year-on-year quarterly revenue growth grew by 49.1%, now sitting on 629.61M for the twelve trailing months.

Sturm, Ruger & Company’s Stock Yearly Top and Bottom Value

Sturm, Ruger & Company’s stock is valued at $81.76 at 14:15 EST, way below its 52-week high of $92.49 and way above its 52-week low of $58.70.

Sturm, Ruger & Company’s Moving Average

Sturm, Ruger & Company’s value is above its 50-day moving average of $81.25 and way higher than its 200-day moving average of $72.09.

More news about Sturm, Ruger & Company.

7. Healthcare Realty Trust Incorporated (HR) – Dividend Yield: 4%

Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of June 30, 2020, the Company owned 210 real estate properties in 24 states totaling 15.5 million square feet and was valued at approximately $5.5 billion. The Company provided leasing and property management services to 12.0 million square feet nationwide.

Volume

Today’s last reported volume for Healthcare Realty Trust Incorporated is 175179, 81.34% below its average volume of 938631.

Healthcare Realty Trust Incorporated’s last close was $30.59, 10.06% below its 52-week high of $34.01.

Healthcare Realty Trust Incorporated’s Revenue

Year-on-year quarterly revenue growth grew by 4.4%, now sitting on 504.31M for the twelve trailing months.

Healthcare Realty Trust Incorporated’s Stock Yearly Top and Bottom Value

Healthcare Realty Trust Incorporated’s stock is valued at $30.32 at 14:15 EST, way below its 52-week high of $34.01 and way higher than its 52-week low of $26.77.

Healthcare Realty Trust Incorporated’s Moving Average

Healthcare Realty Trust Incorporated’s worth is below its 50-day moving average of $30.84 and under its 200-day moving average of $30.55.

More news about Healthcare Realty Trust Incorporated.

8. Elbit Imaging Ltd. (EMITF) – Dividend Yield: 3.68%

Elbit Imaging Ltd., together with its subsidiaries, engages in research and development, production, and marketing of treatment-oriented medical systems; and products to treat cancer diseases. Its treatment-oriented medical systems include magnetic resonance imaging for the purpose of performing noninvasive treatments in human beings. The company is also involved in the sale of plots in India. It has operations in the United States, Europe, and internationally. The company was founded in 1996 and is headquartered in Petach Tikva, Israel.

Volume

Today’s last reported volume for Elbit Imaging Ltd. is 75, 99.79% below its average volume of 36195.

Elbit Imaging Ltd.’s last close was $2.10, 22.79% below its 52-week high of $2.72.

Elbit Imaging Ltd.’s Stock Yearly Top and Bottom Value

Elbit Imaging Ltd.’s stock is valued at $2.54 at 14:15 EST, below its 52-week high of $2.72 and way higher than its 52-week low of $0.80.

Elbit Imaging Ltd.’s Moving Average

Elbit Imaging Ltd.’s worth is way above its 50-day moving average of $2.28 and way higher than its 200-day moving average of $1.93.

More news about Elbit Imaging Ltd..

9. American Assets Trust (AAT) – Dividend Yield: 2.98%

American Assets Trust, Inc. is a full service, vertically integrated and self-administered real estate investment trust, or REIT, headquartered in San Diego, California. The company has over 50 years of experience in acquiring, improving, developing and managing premier office, retail, and residential properties throughout the United States in some of the nation's most dynamic, high-barrier-to-entry markets primarily in Southern California, Northern California, Oregon, Washington, Texas and Hawaii. The company's office portfolio comprises approximately 3.4 million rentable square feet, and its retail portfolio comprises approximately 3.1 million square feet. In addition, the company owns one mixed-use property (including approximately 97,000 rentable square feet of retail space and a 369-room all-suite hotel) and 2,112 multifamily units. In 2011, the company was formed to succeed to the real estate business of American Assets, Inc., a privately held corporation founded in 1967 and, as such, has significant experience, long-standing relationships and extensive knowledge of its core markets, submarkets and asset classes.

Volume

Today’s last reported volume for American Assets Trust is 345761, 16.25% above its average volume of 297417.

American Assets Trust’s last close was $36.55, 6.23% below its 52-week high of $38.98.

The company’s growth estimates for the present quarter is a negative 15.4% and positive 75% for the next.

American Assets Trust’s Revenue

Year-on-year quarterly revenue growth declined by 13%, now sitting on 329.67M for the twelve trailing months.

American Assets Trust’s Stock Yearly Top and Bottom Value

American Assets Trust’s stock is valued at $36.59 at 14:15 EST, under its 52-week high of $38.98 and way higher than its 52-week low of $20.73.

American Assets Trust’s Moving Average

American Assets Trust’s value is below its 50-day moving average of $37.30 and way higher than its 200-day moving average of $33.13.

More news about American Assets Trust.

10. Chesapeake Energy Corporation (CHK) – Dividend Yield: 2.5%

Chesapeake Energy Corporation engages in the acquisition, exploration, and development of properties for the production of oil, natural gas, and natural gas liquids (NGL) from underground reservoirs in the United States. The company holds interests in natural gas resource plays, including the Marcellus in Northern Appalachian Basin in Pennsylvania; Haynesville located in Northwestern Louisiana; Eagle Ford in South Texas; Brazos Valley in Southeast Texas; Powder River Basin in Wyoming; and Mid-Continent in Anadarko Basin of northwestern Oklahoma. As of December 31, 2019, it owned interests in approximately 13,500 oil and natural gas wells; and had estimated proved reserves of 1,572 one million barrels of oil equivalent. The company was founded in 1989 and is headquartered in Oklahoma City, Oklahoma.

Volume

Today’s last reported volume for Chesapeake Energy Corporation is 820362, 44.15% below its average volume of 1468750.

Chesapeake Energy Corporation’s last close was $52.80, 7.35% below its 52-week high of $56.99.

Chesapeake Energy Corporation’s Revenue

Year-on-year quarterly revenue growth declined by 9.3%, now sitting on 5.03B for the twelve trailing months.

Chesapeake Energy Corporation’s Stock Yearly Top and Bottom Value

Chesapeake Energy Corporation’s stock is valued at $54.61 at 14:15 EST, below its 52-week high of $56.99 and way higher than its 52-week low of $40.00.

Chesapeake Energy Corporation’s Moving Average

Chesapeake Energy Corporation’s value is higher than its 50-day moving average of $53.48 and way above its 200-day moving average of $48.08.

More news about Chesapeake Energy Corporation.

LEAVE A REPLY

Please enter your comment!
Please enter your name here